Current Trends in Biotherapeutics
Building upon the Clinical Translation Education Group’s (CTEG) successes in delivering the Bench to Bedside for Biotherapeutics (B3) workshop in 2017 and the IP and Entrepreneurship Workshop in 2018, the CTEG is excited to be hosting a new full-day workshop in fall 2019. This event will introduce trainees and highly-qualified personnel (HQP) to the current trends and disruptive technologies in the biotherapeutics space, including innovative ways of using data to inform decision-making, and solutions for delivering complex cell and gene therapies. This workshop will also provide an opportunity for participants to network and learn about careers in these areas.
Current Trends in Biotherapeutics Workshop
The Clinical Translation Education Group composed of BioCanRx, CCRM, CellCAN, Ontario Institute for Cancer Research (OICR), Ontario Institute for Regenerative Medicine (OIRM) and Stem Cell Network, will be hosting a one-day workshop on current trends and innovations in cell and gene therapy with an emphasis on disruptive technologies. It will be aimed at trainees and other professionals in the biotherapeutic space and will introduce new tools and strategies that are shaping where the biotherapeutic field is headed. Importantly, the workshop will provide an opportunity to network and learn about careers in these areas.
Biotherapeutics have quickly become an increasingly important technology for treating a diverse array of diseases. In recent years the field has made significant progress, and it continues to do so with sophisticated techniques and therapies. Collectively, these trends amplify the increasing demand for improving existing analytical methodologies as well as developing new tools to characterize these complex biological products in greater detail.
Recent developments in biotherapeutic tools and techniques are driving better health outcomes and the commercialization of promising technologies and therapies. This workshop will cover innovative ways of using data to inform decision-making, and solutions for delivering complex cell and gene therapies. These tools and capabilities are being developed in the context of a rapidly changing industry, which may have an impact on the rate and direction of progress. Final products are subject to a commercialization and reimbursement framework that is being challenged by the pace, scale and novelty of this new era of biotechnology. The latter half of this workshop will cover the mechanisms for investment to support commercialization of promising products.
The workshop will look at:
– Major trends of data use to inform preclinical discovery, manufacturing innovations and clinical outcomes
– Trends impacting how cell and gene therapies are commercialized
– Trends in technological solutions for delivering complex therapies to patients and improving access to care
– Potential career paths and opportunities in these various fields
Who Should Attend?
Trainees and HQP with an interest in biotherapeutics and discovering more about disruptive technologies and what they mean for the future of research and medicine.
Workshop Date: Friday, September 27, 2019
Workshop Location: The Chestnut Residence & Conference Centre, 89 Chestnut Street, Toronto, ON M5G 1R1
All those interested in attending the Current Trends in Biotherapeutics workshop should register in advance HERE.
The registration fee for this event is ($CAD):
– $50 registration fee + $4.06 processing fee + $7.03 HST
Travel Support from the Stem Cell Network and CTEG partners
The Stem Cell Network is a proud member of the CTEG, and is pleased to offer a limited number of travel awards to enable eligible trainees to attend this workshop.
Travel awards are also offered by the Ontario Institute for Regenerative Medicine (OIRM) and BioCanRx.
All those who submit an application for travel support will automatically be considered for a travel award through the appropriate CTEG partner.
Travel Support Application Deadline: Wednesday, July 31, 2019
Details of the Travel Support Application Procedure
Awards for travel support will provide financial assistance for eligible trainees / highly qualified personnel to attend this workshop.
– Application deadline is 11:59 PM (sender’s time), Wednesday, July 31, 2019.
– The travel award will cover travel expenses associated with attending the workshop, for trainees not based in Toronto:
– Travel to/from the workshop location
– One night shared accommodation at our designated hotel (the night before the workshop)
– Meals not provided during the workshop
– Reimbursement will be processed following the workshop and in accordance with the applicable travel reimbursement policy (policies will be provided to the selected applicants by the applicable CTEG partner).
– Accommodation during the course will be provided for travel support award winners not based in Toronto. Two trainees of the same gender may be required to share a room.
– The travel award will NOT cover the workshop registration fee.
Eligibility for Travel Support
– Applicants must be:
– For a SCN travel award, a SCN trainee / HQP (i.e. a graduate student, post-doctoral fellow, research associate and/or technician currently working in the field of stem cells and regenerative medicine in a Canadian lab) working on a research project related to stem cells.
– For an OIRM travel award, an OIRM trainee (i.e. graduate student or post-doctoral fellow working in the lab of an OIRM principal investigator).
– For a BioCanRx travel award, a trainee / HQP whose supervisor is funded or co-funded via BioCanRx
– If you’re unsure whether you are a SCN trainee / HQP, please email Jon Draper at firstname.lastname@example.org for confirmation.
– If you’re unsure whether you are an OIRM trainee, please consult the OIRM scientists list to see if your supervisor is part of OIRM or contact email@example.com for confirmation.
– If you’re unsure whether you are a BioCanRx trainee, please email Megan Mahoney at firstname.lastname@example.org for confirmation.
1. Complete the application form and email it, along with any additional documents required, to OIRM at email@example.com by 11:59 PM (sender’s time) Wednesday, July 31, 2019.
2. The CTEG partners’ Training & Education Committees and/or management will review all complete applications, and applicants will be informed of the competition outcome by Friday, August 9, 2019.
By accepting a SCN travel award, the recipient agrees to provide a report describing the value of the training and networking opportunities made available through the award. This information will be used at SCN’s discretion on its website, newsletters and for the purpose of reporting to their funding agencies. Please note that expense reimbursement will be processed only once the completed report is received.
By registering for this workshop attendees acknowledge that their picture may be taken during the workshop, which may be used in the materials described above.
Please contact Rebecca Cadwalader at firstname.lastname@example.org.
*The Clinical Translation Education Group (CTEG)
CTEG is a collaboration, formed in 2016, between six organizations involved in, or supporting, experimental clinical cellular therapy. It was established to address the absence of a high-quality, structured educational training program in the clinical translation of biotherapeutics. The long-term vision of CTEG is to develop a training strategy in clinical translation to cover aspects of research translation from its early discovery to the clinical trial and commercialization stage.
CTEG members are: